It is now clear that inflammation, articular destruction, and the comorbidities associated with RA are mainly triggered by cytokines, ensuring the success of current RA treatment strategies of blocking proinflammatory cytokines such as TNFα, IL-1β or IL-6. Here, TNF is linked to rheumatoid arthritis.